Navigation Links
AMDL's Goodnak(R) Anti-Aging Skin Care Line Soon Available in Capsule & Lotion Form

Easy-to-use formulations help broaden market penetration in China

TUSTIN, Calif., June 24 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), (, a leader in specialty pharmaceuticals, announced today its subsidiary Jade Pharmaceutical, Inc. (JPI) anticipates releasing during the 3rd quarter of 2008 two new formulations of its popular Goodnak(R) anti-aging skin care product line. In addition to its high quality injectable formulation, JPI anticipates offering Goodnak in capsules and an easy-to-apply lotion.

Based on general market information, the proposed pricing for these new formulations will be approximately US$40.00 per unit, with 60% gross profit margins. JPI plans to sell both products through existing distribution channels within the Henan, Sichuan, Guizhou, Shanxi, Xinjiang, Gansu, Hunnan, Zhejiang, Fujian, Liaoning and Heilongjiang Provinces of China. Together these regions have a combined population of more than 376 million people. In addition to China, AMDL believes both products will be good candidates for export to the North American and European markets.

According to Gary Dreher, CEO of AMDL, "With the popularity of the Goodnak brand in China, combined with JPI's ability to sell through pre-approved distribution channels, we anticipate sales to exceed well beyond our initial annual sales forecast for Goodnak of $24 million. This is extremely positive news for the market, Company and our shareholders."

Additional information on AMDL, Goodnak and the Company's other pharmaceutical products is available at

About AMDL:

AMDL, Inc. is a global specialty pharmaceutical Company. The Company is headquartered in Tustin, California with operations in Shenzhen, Jiangxi, and Jilin, China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDL is devoted to the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products currently in China. The Company employs approximately 320 people in the U.S. and China.

About Jade Pharmaceutical:

JPI has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiaries, Jade currently manufactures large volume injection fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact: Kristine Szarkowitz


Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGISTS GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL
2. Parisian Peel(R) Introduces Anti-Aging Suffusion System
3. Anti-Aging/Genetic Health Leader Suracell, Inc. Expands Internationally
4. NeoStrata Research Validates Anti-Aging Benefits of At-Home AHA Peels As Complement to In-Office Non-Invasive Cosmetic Procedures
5. Breakthrough Acai Berry Anti-Aging Facial Applies Benefits of Natures Super-Food to the Skin
6. New ingredients in drug-like anti-aging products improve skin
7. Chinas Anti-Aging Revolution
8. AUDIO from Medialink and Allergan: Women Not Sure Who to Trust on Anti-Aging Skin Care
9. TRIA Personal Laser Hair Removal System Now Available at Aesthetic Physician Offices
10. WuXi PharmaTech 2007 Annual Report Available Online
11. New Resource Available for Families Seeking Quality Care for Aging Parents
Post Your Comments:
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: